• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Deutsche Telekom bulks up T-Mobile US stake as it sells Dutch unit

September 7, 2021 by David Barret Leave a Comment

September 7, 2021

BERLIN (Reuters) – Deutsche Telekom struck a share-swap deal with Softbank to increase its stake in U.S. unit T-Mobile and sold its Dutch unit in a major restructuring of interests that strengthens the German group’s transatlantic focus.

As a result of the two deals announced on Tuesday, Deutsche Telekom will raise its stake in T-Mobile US by 5.3% to 48.4%, bringing CEO Tim Hoettges closer towards his goal of securing direct majority control over the U.S. telecoms operator.

Softbank will in return receive a 4.5% stake in Deutsche Telekom, establishing a direct shareholding relationship after Softbank sold its U.S. Sprint unit to T-Mobile in a deal that closed in early 2020.

In a separate deal, Deutsche Telekom sold its Dutch unit T-Mobile Netherlands to a consortium of private equity houses Apax and Warburg Pincus for 5.1 billion euros ($6.05 billion).

Deutsche Telekom acquired control of the Dutch business from Sweden’s Tele2 in 2018 but never considered the unit, which ranked a distant third behing market leaders KPN and Vodafone Ziggo, as a core asset.

Deutsche Telekom will invest some of its 3.8 billion euros in proceeds from the Dutch deal to raise its stake in T-Mobile US. Sweden’s Tele2 , which had retained a 25% stake in T-Mobile Netherlands, also sold out.

($1 = 0.8425 euros)

(Reporting by Douglas Busvine; Editing by Emma Thomasson and Kim Coghill)

Source Link Deutsche Telekom bulks up T-Mobile US stake as it sells Dutch unit

David Barret
David Barret

Related posts:

  1. Hackers are hiring more English speakers to write believable email scams
  2. JBL Quantum 350 looks like a great affordable wireless gaming headset
  3. Canada trade surplus narrowed in July to C$778 million
  4. Life insurers shift to pre-pandemic norms after COVID vaccine roll-outs

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Watch Platinum Crystals Forming In Liquid Metal Thanks To “Really Special” New Technique
  • Why Do Cuttlefish Have Wavy Pupils?
  • How Many Teeth Did T. Rex Have?
  • What Is The Rarest Color In Nature? It’s Not Blue
  • When Did Some Ancient Extinct Species Return To The Sea? Machine Learning Helps Find The Answer
  • Australia Is About To Ban Social Media For Under-16s. What Will That Look Like (And Is It A Good Idea?)
  • Interstellar Comet 3I/ATLAS May Have A Course-Altering Encounter Before It Heads Towards The Gemini Constellation
  • When Did Humans First Start Eating Meat?
  • The Biggest Deposit Of Monetary Gold? It Is Not Fort Knox, It’s In A Manhattan Basement
  • Is mRNA The Future Of Flu Shots? New Vaccine 34.5 Percent More Effective Than Standard Shots In Trials
  • What Did Dodo Meat Taste Like? Probably Better Than You’ve Been Led To Believe
  • Objects Look Different At The Speed Of Light: The “Terrell-Penrose” Effect Gets Visualized In Twisted Experiment
  • The Universe Could Be Simple – We Might Be What Makes It Complicated, Suggests New Quantum Gravity Paper Prof Brian Cox Calls “Exhilarating”
  • First-Ever Human Case Of H5N5 Bird Flu Results In Death Of Washington State Resident
  • This Region Of The US Was Riddled With “Forever Chemicals.” They Just Discovered Why.
  • There Is Something “Very Wrong” With Our Understanding Of The Universe, Telescope Final Data Confirms
  • An Ethiopian Shield Volcano Has Just Erupted, For The First Time In Thousands Of Years
  • The Quietest Place On Earth Has An Ambient Sound Level Of Minus 24.9 Decibels
  • Physicists Say The Entire Universe Might Only Need One Constant – Time
  • Does Fluoride In Drinking Water Impact Brain Power? A Huge 40-Year Study Weighs In
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version